fbpx

Ditropan

Active Ingredient:

Oxybutynin HCl

Description:

Voiding symptoms associated with uninhibited neurogenic bladder and reflex neurogenic bladder, spastic neurogenic bladder, nocturia enuresis

Formulations:

5mg (100s) tablets

Therapeutic category:

Urology

Disclaimer

This Medical Information is intended only for healthcare professionals. If you are not a healthcare professional please consult your healthcare provider. The product information contained throughout this website is intended only for information purposes in the country(ies) to which the specific website page and/or product refers. Information relating to all scheduled products is provided exclusively for healthcare professionals who are registered with the relevant regulatory authority, and by accessing such information the visitor warrants that they are appropriately registered with the required authorities and are qualified healthcare professionals. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Pharmaco representative for the latest information specific to your country.